Viiv-Medicines Patent Pool deal looks beyond India for generics partners
This article was originally published in Scrip
Executive Summary
The Medicines Patent Pool wants generics companies from around the world, not just India, to take part in the voluntary license agreement it this week announced with Viiv Healthcare (formed of GlaxoSmithKline, Shionogi and P fizer), said Greg Perry, the Pool's executive director.